Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A Horner

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
The Biochemical Journal|December 15, 1986
Location of antithrombin-binding regions in rat skin heparin proteoglycansK G Jacobsson, U Lindahl, A A Horner
The Biochemical Journal|October 1, 1974
Crystallization of macromolecular heparinE D Atkins, I A Nieduszynski, A A Horner
Springer Seminars in Immunopathology|August 17, 2000
Mucosal adjuvanticity of immunostimulatory DNA sequencesA A Horner, N Cinman, A Ronaghy, et al.
The Biochemical Journal|April 1, 1988
Determination of the range in binding-site densities of rat skin heparin chains with high binding affinities for antithrombinA A Horner, M Kusche, U Lindahl, et al.
The Journal of Experimental Medicine|March 1, 1995
gamma/delta T lymphocytes express CD40 ligand and induce isotype switching in B lymphocytesA A Horner, H Jabara, N Ramesh, et al.
Allergy|July 30, 2002
Immunostimulatory DNA-based therapeutics for experimental and clinical allergyA A Horner, K Takabaysahi, J M Zubeldia, et al.
Springer Seminars in Immunopathology|August 17, 2000
Pre-priming: a novel approach to DNA-based vaccination and immunomodulationH Kobayashi, A A Horner, E Martin-Orozco, et al.
Allergy|April 12, 2001
DNA-based vaccination for the treatment of food allergyM D Nguyen, N Cinman, J Yen, et al.
The Journal of Biological Chemistry|October 10, 1978
A proteoglycan form of heparin and its degradation to single-chain moleculesH C Robinson, A A Horner, M Höök, et al.
Immunological Reviews|April 9, 2001
DNA-based immunotherapeutics for the treatment of allergic diseaseA A Horner, J H Van Uden, J M Zubeldia, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
The Biochemical Journal|December 15, 1986
Location of antithrombin-binding regions in rat skin heparin proteoglycansK G Jacobsson, U Lindahl, A A Horner
The Biochemical Journal|October 1, 1974
Crystallization of macromolecular heparinE D Atkins, I A Nieduszynski, A A Horner
Springer Seminars in Immunopathology|August 17, 2000
Mucosal adjuvanticity of immunostimulatory DNA sequencesA A Horner, N Cinman, A Ronaghy, et al.
The Biochemical Journal|April 1, 1988
Determination of the range in binding-site densities of rat skin heparin chains with high binding affinities for antithrombinA A Horner, M Kusche, U Lindahl, et al.
The Journal of Experimental Medicine|March 1, 1995
gamma/delta T lymphocytes express CD40 ligand and induce isotype switching in B lymphocytesA A Horner, H Jabara, N Ramesh, et al.
Allergy|July 30, 2002
Immunostimulatory DNA-based therapeutics for experimental and clinical allergyA A Horner, K Takabaysahi, J M Zubeldia, et al.
Springer Seminars in Immunopathology|August 17, 2000
Pre-priming: a novel approach to DNA-based vaccination and immunomodulationH Kobayashi, A A Horner, E Martin-Orozco, et al.
Allergy|April 12, 2001
DNA-based vaccination for the treatment of food allergyM D Nguyen, N Cinman, J Yen, et al.
The Journal of Biological Chemistry|October 10, 1978
A proteoglycan form of heparin and its degradation to single-chain moleculesH C Robinson, A A Horner, M Höök, et al.
Immunological Reviews|April 9, 2001
DNA-based immunotherapeutics for the treatment of allergic diseaseA A Horner, J H Van Uden, J M Zubeldia, et al.
Pageof 4